Vivos Therapeutics names Roman Franklin CFO as Bradford Amman resigns

Reuters2026/08/03 21:30

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Vivos Therapeutics named Roman Franklin, 42, as chief financial officer, effective July 31, 2026.
Bradford Amman resigned as CFO and secretary on July 31, 2026; exit described as voluntary with no disputes cited.
Amman will support the handover for 90 days as a non-executive transition employee, then advise for 180 days as an independent contractor.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vivos Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-035867), on August 03, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Vivos Therapeutics names Roman Franklin CFO as Bradford Amman resigns

You may also like

Crypto prices